How can you use a clinic rating wisely?

Which comments are useful?

Give more weight to exact details on calls, wait times, and follow-up. Those points may help you know what to ask before booking. A single harsh or glowing comment may reflect only one person’s experience. Concrete details carry more meaning than praise that gives no example.

Check whether a comment even concerns the service you are considering. Many clinics offer more than one kind of care. A business-wide rating may cover matters unrelated to joint soreness.

Which questions need an exam?

Only an exam can sort arthritis soreness from a tendon or other cause. The visit should cover how the ache began and what worsens it. Prior reports may help the clinic understand what was already checked.

Have the clinic explain the exam findings in everyday words. Ask what care usually comes before a procedure and why. If the answer isn't clear, ask again or talk with your own doctor.

When can you stop reading reviews?

Stop when more comments no longer give you useful questions. Once those questions are ready, more scrolling often adds very little. Compare travel, cost, follow-up, and the ease of reaching the office. Don't treat a small rating difference as a medical finding.

While deciding, pace the activity that makes the joint sore for hours. Keep moving gently enough that stiffness doesn't build through the day. QC Kinetix offers concentrated PRP, the platelet-rich part retained after the clinic separates blood drawn from you.

Evidence sources

1. In the RESTORE trial - the largest placebo-controlled PRP trial in knee osteoarthritis - 288 adults aged 50+ with symptomatic Kellgren-Lawrence grade 2-3 medial knee OA received three weekly intra-articular injections of leukocyte-poor PRP from a commercial system or saline placebo. At 12 months the mean change in knee pain was -2.1 points with PRP versus -1.8 with saline (difference -0.4; 95% CI -0.9 to 0.2; P=.17) against a minimum clinically important difference of 1.8, and the change in medial tibial cartilage volume was -1.4% versus -1.2% (difference -0.2%; 95% CI -1.9% to 1.5%; P=.81). Twenty-nine of 31 prespecified secondary outcomes showed no significant between-group difference. The authors concluded the findings do not support use of PRP for knee OA.

   Bennell KL, Paterson KL, Metcalf BR, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA, 2021.

2. The ESSKA-ICRS consensus applied the RAND/UCLA appropriateness method to 216 clinical scenarios for intra-articular PRP in knee OA. Only 84 scenarios (38.9%) were rated appropriate, 9 (4.2%) inappropriate and 123 (56.9%) uncertain. PRP was judged appropriate in patients aged 80 or under with KL grade 0-III osteoarthritis AFTER failed conservative non-injective or injective treatment; it was NOT considered appropriate as a first treatment, nor in KL grade IV (bone-on-bone) osteoarthritis, where 91.7% and 87.5% of scenarios respectively were uncertain.

   Kon E, de Girolamo L, Laver L, et al. — Platelet-rich plasma injections for the management of knee osteoarthritis: The ESSKA-ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios. Knee Surgery, Sports Traumatology, Arthroscopy, 2024.

3. The American Academy of Physical Medicine and Rehabilitation convened a technical expert panel that ran a structured literature review (2023, updated through June 2025) and a modified Delphi process, and issued five evidence-based clinical recommendations plus 11 consensus-based best practices for PRP in knee osteoarthritis. The statement is explicit that orthobiologic therapies 'remain an evolving area of practice' and that robust, dose-dependent randomized controlled trials are still needed to establish PRP's clinical effects.

   Borg-Stein J, Jayaram P, Colorado BS, et al. — AAPM&R guidance statement on platelet rich plasma for knee osteoarthritis. PM&R, 2026.